SCIRENT Clinical Research and Science
SCIRENT is a specialized contract research organization (CRO) founded in 2012, focusing on cardiovascular research. It offers tailored solutions for clinical trials, including services in clinical operations, regulatory support, and medical expertise, with a strong network of research sites in Europe and North America. The company's mission is to help develop innovative therapies and medical devices for patients with cardiovascular diseases, emphasizing speed, quality, and expertise in the field.
Industries
Nr. of Employees
medium (51-250)
SCIRENT Clinical Research and Science
Amrumer Str. 16, 13353 Berlin, Germany
Services
Feasibility assessments, site selection, ethics/IRB and regulatory submissions, and site initiation to enable study activation.
Full-service project and operational management across clinical phases with senior leadership oversight.
Regulatory strategy, dossier preparation and interactions with ethics committees and national competent authorities, including device regulatory frameworks.
On-site and remote monitoring operations delivered by CRAs, including monitoring of cardiovascular-specific assessments.
Ongoing safety oversight and medical monitoring to manage adverse events and trial safety issues.
Statistical design, data management, centralized analytics and data-driven monitoring to ensure data integrity and balanced populations.
Feasibility assessments, site selection, ethics/IRB and regulatory submissions, and site initiation to enable study activation.
Full-service project and operational management across clinical phases with senior leadership oversight.
Regulatory strategy, dossier preparation and interactions with ethics committees and national competent authorities, including device regulatory frameworks.
On-site and remote monitoring operations delivered by CRAs, including monitoring of cardiovascular-specific assessments.
Ongoing safety oversight and medical monitoring to manage adverse events and trial safety issues.
Statistical design, data management, centralized analytics and data-driven monitoring to ensure data integrity and balanced populations.
Expertise Areas
- Cardiovascular clinical trial management
- Medical device clinical trials (cardiovascular focus)
- Early-phase (Phase I) and later-phase (Phase II–IV) studies
- Integrated Phase I/PoC trial design (healthy volunteers and patients)
Key Technologies
- Echocardiography and centralized imaging analysis
- Telemedicine and remote patient monitoring
- Centralized data review and analytics
- Electronic data capture and cloud-based document management
News & Updates
The congress was a significant event for SCIRENT, highlighting local clinical expertise and scientific contributions in cardiovascular research.
SCIRENT will attend the American College of Cardiology's Annual Scientific Session ACC.25 in Chicago, showcasing expertise in cardiovascular trials and partnerships.
SCIRENT will participate in the THT Conference in Boston, focusing on advanced therapies and technologies in cardiovascular medicine.
SCIRENT will participate in the ESC Congress in London, showcasing innovative approaches in cardiovascular clinical research.
SCIRENT will participate in the TCT Conference in San Francisco, a premier event for interventional cardiovascular medicine.
Milestones in clinical trials are closely tied to investor payments. Adherence to timelines is crucial for securing funding and ensuring trial success.
The congress was a significant event for SCIRENT, highlighting local clinical expertise and scientific contributions in cardiovascular research.
SCIRENT will attend the American College of Cardiology's Annual Scientific Session ACC.25 in Chicago, showcasing expertise in cardiovascular trials and partnerships.
SCIRENT will participate in the THT Conference in Boston, focusing on advanced therapies and technologies in cardiovascular medicine.
SCIRENT will participate in the ESC Congress in London, showcasing innovative approaches in cardiovascular clinical research.
SCIRENT will participate in the TCT Conference in San Francisco, a premier event for interventional cardiovascular medicine.
Milestones in clinical trials are closely tied to investor payments. Adherence to timelines is crucial for securing funding and ensuring trial success.